Find clinical trials for Colon Cancer in Hanyang, Seoul
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Colon Cancer trials near Hanyang, Seoul, KOR:
(SOC) in participants with untreated T4N0 or Stage III (resectable), defective mismatch repair/ microsatellite instability high (dMMR/MSI-H) colon...
Phase 3
Seoul, South Korea and 262 other locations
aggressive and challenging to treat. The study will test whether GSK4418959 alone or in combination with a PD-1 inhibitor agent can decrease tumor...
Phase 1, Phase 2
Seoul, South Korea and 21 other locations
true for cases requiring surgery after early-stage colorectal cancer or endoscopic tumor resection. Therefore, preoperative markin...
Seoul, Seoul, South Korea
dehydrogenase 1 (IDH1) arginine 132 (R132)-mutant advanced solid tumors, including but not limited to cholangiocarcinoma, chondrosarcoma, an...
Phase 1
Seoul, Seoul-teukbyeolsi [Seoul], South Korea and 32 other locations
To confirm the safety and performance of the da Vinci SP Surgical System, Instruments and Accessories in a complex colorectal procedure such as low a...
Seoul, Gangseo-gu, Korea, Republic of and 8 other locations
This is an open-label, first-in-human study designed to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor ...
Phase 1, Phase 2
Seoul, Seoul-teukbyeolsi [Seoul], South Korea and 85 other locations
inhibitor) monotherapy in adult subjects with advanced solid tumors and to identify the maximum tolerated dose (MTD), and the recommended Ph...
Phase 1
Seoul, South Korea and 63 other locations
oral LOXO-292 in pediatric participants with an activating rearranged during transfection (RET) alteration and an advanced solid or primary CNS tumor...
Phase 1, Phase 2
Seoul, Korea, South Korea and 25 other locations
in combination with pembrolizumab in patients with select advanced cancers, and to identify the maximum tolerated dose and/or recommended do...
Phase 1
Seoul, South Korea and 18 other locations
chemotherapy and bevacizumab with or without INCA33890 in the first-line treatment of metastatic microsatellite stable colorectal cancer....
Phase 3
Seoul, South Korea and 273 other locations
Clinical trials
Research sites
Resources
Legal